UNITY Biotechnology

2023 was a pivotal year for UNITY.     As we turn the page to 2024, we’re looking forward to continuing our mission to redefine the treatment paradigm for #DME. With many upcoming milestones, we’re thrilled to continue our momentum into the new year. Stay tuned for more to come!     #UBX1325 #JPM24 #ReimagineAging 

Join UNITY Biotechnology (#UBX) on Tues, Oct. 15 at 8am ET in New York or virtually for its Ophthalmology Day for investors and analysts, featuring Robert Bhisitkul, MD, PhD (UCSF School of Medicine), Arshad Khanani, MD, MA, FASRS (Sierra Eye Associates, University of Nevada Reno School of Medicine), and Dante Pieramici, MD (California Retina Consultants). Register here: https://bit.ly/4gBf6rd

Save the date! Join us at our Ophthalmology Day for Investors and Analysts on October 15, 2024 in New York, NY.     Our in-person and virtual event will feature presentations from prominent retina experts and members of the UNITY management team. We will focus on the latest data from our diabetic macular edema program and the ongoing Phase 2b ASPIRE study evaluating #UBX1325 head-to-head against aflibercept in DME. Additionally, a Q&A session will follow the formal presentations.     See you there!     Learn more details and register here: https://bit.ly/3ZEz66f

High blood sugar comes with a wide array of negative side effects. In diabetic patients, cellular senescence caused by sustained hyperglycemia damages the blood vessels in the retina – a key feature of #DME – and leads to vision loss. Our senolytic candidate #UBX1325 targets senescent cells in the retina, potentially reducing local inflammation and restoring vision in diabetic patients. Learn more: https://bit.ly/478Viac  

This Monday, our CEO Anirvan Ghosh, Ph.D. will provide a corporate update and company presentation at the H.C. Wainwright & Co., LLC 26th Annual Global Investment Conference. Learn more and register for the live webcast: https://bit.ly/4e0zGPz

Happy National Dog Day from UNITY Biotechnology! 🐶 We're pawsitively thrilled to celebrate our favorite four-legged friends who bring endless joy, love, and a little bit of fur to our lives! Whether they're fetching their favorite toy or curling up by our feet during Zoom meetings, our canine companions are the ulti-mutt team members, always ready to lend a paw. 🐾   Here's to the bark-tastic bond we share with our dogs— they're the real MVPs (Most Valuable Pups)!    #NationalDogDay #UltiMuttTeam

Our senolytic candidate UBX1325 is designed to enter the retina, eliminate senescent cells, and allow damaged tissue to heal itself. This disease-modifying approach could change the way we treat retinal diseases like #DME and potentially restore vision in patients.    Listen to Chief Scientist Mike (Przemyslaw) Sapieha, Ph.D. break down #UBX1325’s mechanism of action in DDN Dialogues’ podcast episode “Rejuvenating the retina to save vision” below and online here: https://bit.ly/3VBfCf7  

How are senescent cells cleared? As we grow older our immune system is no longer able to effectively eliminate senescent cells, causing their accumulation to become more prominent and potentially causing health complications. In DME, this manifests as vision loss. #UBX1325 is designed to selectively target and eliminate senescent cells in the retina, potentially improving vision for #DME patients. Learn more about our scientific approach: https://bit.ly/3UN4PNJ  

How are senescent cells cleared? As we grow older our immune system is no longer able to effectively eliminate senescent cells, causing their accumulation to become more prominent and potentially causing health complications. In DME, this manifests as vision loss. #UBX1325 is designed to selectively target and eliminate senescent cells in the retina, potentially improving vision for #DME patients. Learn more about our scientific approach: https://bit.ly/3UN4PNJ  

Join our CEO Anirvan Ghosh, Ph.D. at the H.C. Wainwright & Co., LLC 4th Annual Ophthalmology Virtual Conference this week, where he will host a virtual company presentation.     Learn more and access the live webcast: https://lnkd.in/eKmpDKFb